Dr Andrea Wessel, MD in Moosic, PA - Family Medicine

Dr Andrea Wessel, MD is a Family Medicine physician based in Moosic, Pennsylvania. Dr Andrea Wessel is licensed to practice in Pennsylvania (license number MD422757) and her current practice location is 4004 Birney Ave, Moosic, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (570) 344-4711.

NPI number for Dr Andrea Wessel is 1427009554 and her current mailing address is 100 N Academy Ave, Danville, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1427009554.

Contact Information

	Dr Andrea Wessel, MD
	4004 Birney Ave, Moosic, PA 18507-1312
	(570) 344-4711
	(570) 344-2238

Physician's Profile

Full Name	Dr Andrea Wessel
Gender	Female
Speciality	Family Medicine
Location	4004 Birney Ave, Moosic, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1427009554
Provider Enumeration Date: 05/13/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Andrea Wessel such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427009554	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	MD422757 (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Andrea Wessel is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Andrea Wessel, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144	Dr Andrea Wessel, MD 4004 Birney Ave, Moosic, PA 18507-1312 Ph: (570) 344-4711

News Archive

Research explores the biophysical behavior of SARS-CoV-2 nucleocapsid protein

In a groundbreaking paper currently available on the bioRxiv* preprint server, the researchers from the Washington University School of Medicine and Stony Brook University showed how nucleocapsid protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is dynamic, disordered and phase separates with RNA – informing, in turn, the discovery of drugs that disrupt viral packaging.

Affymetrix files more patent infringements against Illumina in U.S. and Europe

Affymetrix Inc. has announced that it has filed additional patent infringement lawsuits against Illumina Inc. in the United States District Court for the District of Delaware, in the U.K. High Court of Justice, Chancery Division, Patents Court and in the German, Düsseldorf Regional Court, Patent Division. Affymetrix is seeking all available remedies, including injunctive relief.

U.S. led initiative will provide small business loans to support people with AIDS

A new U.S.-led initiative aims to reduce the "stigmatization" of people living with HIV/AIDS by associating HIV-positive people with successful businesses and encouraging cooperation between those with the disease and others in the community.

PD0325901 drug may hold potential to prevent neurofibromatosis 1 in children

A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.

Dr Andrea Wessel, MD - Family Medicine in Moosic, PA